Tag: porcine epidemic diarrhea vaccines market share

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Bevacizumab Biosimilars Market Expected to Be in 2029?

In recent times, there has been considerable growth in the size of the market for porcine epidemic diarrhea vaccines. It is expected to expand from $1.67 billion in 2024 to $1.8 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.7%. The notable growth witnessed in the historic phase can majorly be accredited to significant vaccination campaigns, enhanced immunization programs (EPI), the rise in the use of disposable syringes, endeavors towards eradicating diarrhea, and initiatives such as the global alliance for vaccines and immunization (GAVI).

In the coming years, the market size for porcine epidemic diarrhea vaccines is predicted to experience considerable expansion. It is forecasted to increase to “$2.37 billion by 2029, advancing at a compound annual growth rate (CAGR) of 7.1%. The projected growth during this period can be linked to factors such as increased focus on immunization initiatives, a growing development pipeline of vaccines, expanding pig populations, attention to cold chain management, and heightened awareness of the need for preventative healthcare. Anticipated trends during this forecast period include ongoing advancements in vaccine delivery device technology, a shift towards needle-free solutions, progress in personalized medicine, increased inclination for self-administered vaccines, and the enhancement of animal healthcare infrastructure and distribution networks.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp

What Are The Contributors To Demand In The Bevacizumab Biosimilars Market?

The increasing rates of cancer diagnoses are anticipated to fuel the advancement of the bevacizumab biosimilar market in the future. The incidence of cancer pertains to the emergence of new instances of cancer in a certain population within a specific timeframe. Bevacizumab, a biological inhibitor of tumor angiogenesis, can cause tumors to recede and hinder their growth, and is as effective and safe as its reference biologic equivalent in treating patients with advanced non-small cell lung cancer or metastatic colorectal cancer. As an example, in October 2024, the National Health Service (NHS) in the UK reported 346,217 new cancer diagnoses, averaging 948 cases daily in 2022, representing a 5% growth in comparison to the 329,664 diagnoses in 2021. There was also a 7% elevation in cancer diagnoses, escalating from 167,917 to 180,877 in 2022. Consequently, the escalating prevalence of cancer is a significant driver for the bevacizumab biosimilars market.

The porcine epidemic diarrhea vaccines market covered in this report is segmented –

1) By Product: Live Vaccines, Killed Vaccines

2) By Application: Piglets, Adults Pigs

3) By End-User: Veterinary Hospitals, Hog Production Farms

Subsegments:

1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines

2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines

What Upcoming Trends Are Expected To Impact The Bevacizumab Biosimilars Market Globally?

Leading businesses in the market for porcine epidemic diarrhea vaccines are focusing on the innovation of products like the Porcine Parvovirus (PPV) vaccine, in order to cement their market dominance. The veterinary immunization known as the PPV vaccine is designed to avoid reproductive issues in pigs which can be caused by PPV, a tiny, non-enveloped virus related to infertility, stillbirths, mummified fetuses, and frail piglets. For instance, in March 2022, the German pharmaceutical firm Boehringer Ingelheim debuted its ReproCyc ParvoFLEX porcine parvovirus (PPV) vaccine. This cutting-edge vaccine is engineered to counter reproductive problems in pigs, such as infertility, stillbirths, mummified fetuses, and fragility in piglets, which possibly can be caused by PPV. What makes this launch special is the vaccine’s sophisticated formulation and efficiency, which provides extensive defense against reproductive damage caused by PPV, thus safeguarding pig herds’ health and productivity.

Who Are The Top-Ranked Companies In The Bevacizumab Biosimilars Market Today?

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

How Is Bevacizumab Biosimilars Market Adoption Varying Across Different Regions And Sectors?

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16514&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Porcine Epidemic Diarrhea Vaccines Market, and What Factors Will Drive It?

The market for vaccines for porcine epidemic diarrhea has experienced significant expansion in the recent past. The market is projected to increase from $1.67 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. The growth observed during the historic period can be credited to major vaccination drives, extended immunization programs (EPI), the use of disposable syringes, initiatives to wipe out diarrhea, and strategies such as the global alliance for vaccines and immunization (GAVI).

There is an anticipated robust expansion in the porcine epidemic diarrhea vaccines market in the upcoming years, with a projected value of $2.37 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.1%. The acceleration in the predicted period can be ascribed to the escalating emphasis on vaccination initiatives, wider vaccine development schemes, increasing pig counts, concentration on cold chain administration, and growing consciousness about the necessity of preventive health measures. The significant trends expected in this period encompass ongoing innovation in vaccine delivery instrument technology, a shift towards needle-free alternatives, advancements in personalized healthcare, a rising inclination towards vaccines administered independently, and the fortifying of animal health infrastructure and distribution networks.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp

Which Primay Drivers Are Accelerating Growth in the Porcine Epidemic Diarrhea Vaccines Market?

The expansion of pig farming is projected to fuel the porcine epidemic diarrhea vaccine market’s growth. This type of farming involves the breeding, rearing, and management of domestic pigs from birth to market weight for meat production, in addition to the marketing and sale of pork products. The growth in pig farming can be attributed to the escalating global interest in pork products, advancements in breeding and management strategies, tech-driven improvements in farming methods, and widening markets for pork consumption. To prevent and control PED outbreaks, porcine epidemic diarrhea vaccines are used in pig farming, typically either through injection or orally starting from the sow’s gestation period. This protects newborn piglets by transferring passive immunity through colostrum. The United States Department of Agriculture, a US government department, has reported that pork production in the United States saw a 1 percent increase over the previous year, reaching 40.6 billion pounds in 2022. As such, the growth of the porcine epidemic diarrhea vaccine market is being driven by the expanding pig farming industry.

Which Primary Segments of the Porcine Epidemic Diarrhea Vaccines Market Are Driving Growth and Industry Transformations?

The porcine epidemic diarrhea vaccines market covered in this report is segmented –

1) By Product: Live Vaccines, Killed Vaccines

2) By Application: Piglets, Adults Pigs

3) By End-User: Veterinary Hospitals, Hog Production Farms

Subsegments:

1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines

2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16514&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Porcine Epidemic Diarrhea Vaccines Market?# Market?

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Porcine Epidemic Diarrhea Vaccines Industry Dynamics?

Leading firms in the market for porcine epidemic diarrhea vaccines are introducing novel products like the porcine parvovirus (PPV) vaccine to bolster their market presence. The PPV vaccine, designed for animal use, aims to prevent reproduction failures in pigs due to the PPV, a tiny, non-enveloped virus linked to infertility, mummified foetuses, stillbirths, and debilitated piglets. For example, in March 2022, the German pharmaceutical company Boehringer Ingelheim unveiled the ReproCyc ParvoFLEX porcine parvovirus (PPV) vaccine. Designed innovatively to fight reproduction failures in pigs, this vaccine, attributed to a small, non-enveloped virus, is aimed at addressing issues like infertility, mummified foetuses, stillbirths, and weak piglets. The distinction of this vaccine launch is the sophisticated formulation and effectiveness, providing full-scale defense against PPV-induced reproductive failures, thus protecting the health and productivity of pig populations.

View the full report here:

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

What Parameters Are Used to Define the Porcine Epidemic Diarrhea Vaccines Market?

Porcine epidemic diarrhea (PED) vaccines are biological preparations developed to provide immunity against the porcine epidemic diarrhea virus (PEDV), which causes severe gastrointestinal disease in pigs. These vaccines are essential tools in preventing and controlling Porcine Epidemic Diarrhea, contributing to the health and productivity of pig populations and the economic stability of the swine industry.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16514

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Porcine Epidemic Diarrhea Vaccines Market Growth Performance Trended Historically, And What Lies Ahead?_x000D_

The market size for porcine epidemic diarrhea vaccines has seen robust growth in the past few years. The market is predicted to increase from $1.67 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. This growth in the historical timeframe can be credited to extensive vaccination drives, widened immunization programs (EPI), the utilization of disposable syringes, efforts to eradicate diarrhea, and endeavors such as the global alliance for vaccines and immunization (GAVI)._x000D_

_x000D_

#What Is the Forecast for the Porcine Epidemic Diarrhea Vaccines Market Size Through 2029?#_x000D_

In the coming years, the market for porcine epidemic diarrhea vaccines is expected to witness significant growth, with an estimated worth of $2.42 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.6%. Factors contributing to this growth trend foreseeably include the increasing emphasis on vaccination programs, advanced vaccine development pathways, growing pig populations globally, prioritization of cold chain management, and heightened awareness about preventive health strategies. The upcoming trends consist of continual advancements in vaccine delivery device technology, a growing focus on needle-less solutions, improvements in personalized medicine, a rising inclination towards self-vaccination, and reinforcing of the animal health infrastructure and distribution networks._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp_x000D_

_x000D_

#What are the Key Market Players in Porcine Epidemic Diarrhea Vaccines Market and How They’re Evolving?#_x000D_

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc_x000D_

_x000D_

#What Are the Primary Growth Drivers in the Porcine Epidemic Diarrhea Vaccines Market?#_x000D_

The surge in pig farming is expected to fuel the expansion of the porcine epidemic diarrhea vaccine market. This kind of farming involves the raising of domestic pigs for meat, breeding, rearing from birth to market weight, and selling pork products. The escalation in pig farming is driven by the incrementing global demand for pork, enhancements in breeding and management practices, technological advancements in farming methodologies, and the growth of markets for pork consumption. Vaccines for porcine epidemic diarrhea (PED) play a crucial role in pig farming to mitigate and control outbreaks. These vaccines are typically administered through injection or orally, beginning from the sow’s gestation period to pass on immunity to newborn piglets via colostrum. For instance, 2022 recorded a pork production of 40.6 billion pounds in the United States, representing a 1 percent rise from the preceding year, as documented by the United States Department of Agriculture, a US governmental department. As a result, the surge in pig farming is stimulating the expansion of the porcine epidemic diarrhea vaccine market._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=16514&type=smp_x000D_

_x000D_

#What Are the Leading Segments in the Global Porcine Epidemic Diarrhea Vaccines Industry?#_x000D_

The porcine epidemic diarrhea vaccines market covered in this report is segmented –_x000D_

_x000D_

1) By Product: Live Vaccines, Killed Vaccines_x000D_

2) By Application: Piglets, Adults Pigs_x000D_

3) By End-User: Veterinary Hospitals, Hog Production Farms_x000D_

_x000D_

Subsegments:_x000D_

1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines_x000D_

2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines_x000D_

_x000D_

#What Are the Key Market Trends in the Porcine Epidemic Diarrhea Vaccines Industry?#_x000D_

Leading firms in the porcine epidemic diarrhea vaccines market are enhancing their market presence through the introduction of cutting-edge products like the Porcine Parvovirus (PPV) vaccine. Designed as a veterinary inoculation, the PPV vaccine plays a critical role in mitigating the risk of reproductive failure in pigs triggered by PPV – a minor, non-enveloped virus which is linked to infertility, stillbirths, mummified fetuses, and frail piglets. To illustrate, Boehringer Ingelheim, a German pharmaceutical enterprise, rolled out the ReproCyc ParvoFLEX porcine parvovirus (PPV) vaccine in March 2022. The newly released vaccine aims to tackle the reproductive failure in pigs, particularly the infertility, stillbirths, mummified fetuses, and weak piglets associated with PPV, a minor, non-enveloped virus. The launch stands out due to its advanced formulation and the effectiveness of the vaccine. It allows a broad-spectrum cover against PPV-induced reproductive losses, hence ensuring the health and productivity of pig herds are sustained._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report_x000D_

_x000D_

#What Is the Regional Outlook for the Porcine Epidemic Diarrhea Vaccines Market?#_x000D_

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16514_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the porcine epidemic diarrhea vaccines market, and how is it changing globally?_x000D_

2. Who are the major companies in the porcine epidemic diarrhea vaccines market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the porcine epidemic diarrhea vaccines market right now?_x000D_

4. Which products or customer segments are growing the most in the porcine epidemic diarrhea vaccines market?_x000D_

5. What factors are helping or slowing down the growth of the porcine epidemic diarrhea vaccines market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of thePorcine Epidemic Diarrhea Vaccines Market from 2025 to 2034?

The increasing pig farming is expected to propel the growth of the porcine epidemic diarrhea vaccine market. Pig farming includes raising pigs for meat production, breeding, rearing, and managing them until market weight. Factors like rising global demand for pork, advancements in breeding and farming techniques, and expanding pork markets are contributing to the rise in pig farming. Porcine epidemic diarrhea (PED) vaccines are essential in preventing and managing outbreaks. In 2022, the U.S. pork production reached 40.6 billion pounds, marking a 1% increase from the previous year. As pig farming continues to grow, the demand for PED vaccines is also expected to increase.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp

#What Are the Key Projections for the CAGR of the Porcine Epidemic Diarrhea Vaccines Market From 2025 to 2034?

The porcine epidemic diarrhea vaccines market size has experienced strong growth, increasing from $1.67 billion in 2024 to $1.8 billion in 2025, with a CAGR of 8.0%. This growth can be attributed to large-scale vaccination campaigns, expanded immunization programs, the adoption of disposable syringes, and global vaccination initiatives.

The porcine epidemic diarrhea vaccines market is forecast to grow to $2.42 billion in 2029 at a CAGR of 7.6%, driven by immunization programs, vaccine development, and the expansion of pig populations. Trends include needle-free solutions, advancements in personalized medicine, and stronger healthcare infrastructure.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16514

How Are Market Trends and Innovations Revolutionizing thePorcine Epidemic Diarrhea Vaccines Industry in Recent Times?

Companies in the porcine epidemic diarrhea vaccines market are developing innovative vaccines like the porcine parvovirus (PPV) vaccine to strengthen their market position. In March 2022, Boehringer Ingelheim launched ReproCyc ParvoFLEX, a vaccine designed to prevent reproductive failure in pigs caused by PPV. This vaccine addresses infertility, stillbirths, and weak piglets, offering comprehensive protection against reproductive losses.

Which Key Market Players Are Shaping the Future and Growth of thePorcine Epidemic Diarrhea Vaccines Market?

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

What Are the Core Segments of the Porcine Epidemic Diarrhea Vaccines Market, and How Do They Contribute to Growth?

The porcine epidemic diarrhea vaccines market covered in this report is segmented –

1) By Product: Live Vaccines, Killed Vaccines

2) By Application: Piglets, Adults Pigs

3) By End-User: Veterinary Hospitals, Hog Production Farms

Subsegments:

1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines

2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=16514&type=smp

What Regions Are Dominating the Porcine Epidemic Diarrhea Vaccines Market Growth?

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Porcine Epidemic Diarrhea Vaccines Market 2025, By The Business Research Company:

Cancer Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the porcine epidemic diarrhea vaccines market size evolved in recent years?

The market size of vaccines for porcine epidemic diarrhea has seen robust growth in the past few years. It is projected to expand from $1.67 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. The historic period growth is largely owed to extensive vaccination drives, broadened immunization programs, the use of disposable syringes, efforts to eliminate diarrhea, and initiatives such as the Global Alliance for Vaccines and Immunization (GAVI).

What are the predictions for the porcine epidemic diarrhea vaccines market size in the coming years?

The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.42 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pig populations, focus on cold chain management, and rising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, growing preference for self-administered vaccines, and strengthening animal healthcare infrastructure and distribution networks.

Get your porcine epidemic diarrhea vaccines market report here!

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

What key factors are fueling the growth of the porcine epidemic diarrhea vaccines market?

Anticipated advancements in the porcine epidemic diarrhea vaccine market can be attributed to the rise in pig farming. This particular farming process, which involves breeding, nurturing, and managing domestic pigs from birth until they’re ready for sale, as well as marketing and selling pork products, is seeing a surge due to several factors. The key factors behind this surge involve an augmented worldwide demand for pork products, refined breeding and management tactics, advances in farming procedures, and expansion of pork consumption markets. Porcine epidemic diarrhea (PED) vaccines play a crucial role in pig farming by controlling and preventing possible disease outbreaks. These vaccines are typically given either orally or via injection during the sow’s gestation period, which provides passive immunity to the newborn piglets via colostrum. A concrete example of this growth is that the pork production in the United States reached 40.6 billion pounds in 2022, according to the United States Department of Agriculture, representing a 1 percent increase from the previous year. Therefore, it’s expected that the surge in pig farming will further fuel the growth of the porcine epidemic diarrhea vaccine market.

How is the global porcine epidemic diarrhea vaccines market divided into key segments?

The porcine epidemic diarrhea vaccines market covered in this report is segmented –

1) By Product: Live Vaccines, Killed Vaccines

2) By Application: Piglets, Adults Pigs

3) By End-User: Veterinary Hospitals, Hog Production Farms

Subsegments:

1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines

2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp

Who are the key firms paving the way for growth in the porcine epidemic diarrhea vaccines market?

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc

What key trends are currently impacting the porcine epidemic diarrhea vaccines market’s development?

Leading firms in the porcine epidemic diarrhea vaccines market are advancing their market position through the creation of novel products like the porcine parvovirus (PPV) vaccine. Designed as a veterinary immunization, the PPV vaccine aims to combat reproductive issues in pigs linked to PPV, a non-enveloped virus causing infertility, stillbirth, mummified fetuses, and frail piglets. Boehringer Ingelheim, a pharmaceutical company based in Germany, debuted the ReproCyc ParvoFLEX porcine parvovirus (PPV) vaccine in March 2022. This ground-breaking vaccine is formulated to fight against reproductive problems in pigs such as infertility, stillbirths, mummified fetuses, and weak piglets, all caused by PPV, a small, non-enveloped virus. The notable innovation of this product release is in the vaccine’s advanced composition and effectiveness, delivering wide-ranging protection against PPV-related reproductive harm and, therefore, protecting the health and yield of pig populations.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16514

What regions are contributing significantly to the growth of the porcine epidemic diarrhea vaccines market?

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cancer Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Analyzing the Growth Rate of the Porcine Epidemic Diarrhea Vaccines Market: What’s the Expected CAGR for the Next Decade?

The market for porcine epidemic diarrhea vaccines has experienced substantial growth in recent years, with the size projected to rise from $1.67 billion in 2024 to $1.8 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.0%. The surge observed in the historical period is a result of widespread vaccination drives, enhanced immunization programs (EPI), the utilization of disposable syringes, endeavors to eradicate diarrhea, and partnerships such as the global alliance for vaccines and immunization (GAVI).

Expectations are high for the porcine epidemic diarrhea vaccines market to experience significant expansion in the upcoming years, with projections suggesting a rise to $2.42 billion in 2029, representing a compound annual growth rate (CAGR) of 7.6%. This predicted growth during the projection period is credited to an increased focus on immunization programs, a wide-ranging vaccine development pipeline, growing pig populations, emphasis on cold chain management, and heightening awareness of the value of preventive health measures. Other anticipated trends during this period include ongoing innovations in vaccine delivery device technology, a shift towards needle-free solutions, progress in personalised medicine, an increasing preference for self-administered vaccines, along with improvements in animal healthcare systems and distribution networks.

How Are the key drivers expanding the growth of the Porcine Epidemic Diarrhea Vaccines Market?

The growth of the porcine epidemic diarrhea vaccine market is expected to be driven by the surge in pig farming. This agricultural practice entails the breeding, raising, management, marketing, and selling of domestic pigs, primarily for meat production. This growth in pig farming is fueled by higher global demand for pork products, advancements in breeding and management methods, innovative farming techniques, and the growth of markets for pork consumption. To prevent and manage contagion, porcine epidemic diarrhea (PED) vaccines are used in pig farming. These vaccines, administered either through injection or orally, are usually initiated during the sow’s gestation period to pass on passive immunity to the newborn piglets via colostrum. For example, data from the United States Department of Agriculture, a US government department, shows that in 2022, pork production in the US amounted to 40.6 billion pounds, a 1 percent rise from the previous year. Therefore, the surge in pig farming is propelling the porcine epidemic diarrhea vaccine market forward.

Request Your Free Porcine Epidemic Diarrhea Vaccines Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp

What Are the Leading Organizations Impacting the Porcine Epidemic Diarrhea Vaccines Market’s Growth?

Major companies operating in the porcine epidemic diarrhea vaccines market are:

• Zoetis Inc._x000D_

• Merck Animal Health_x000D_

• Elanco Animal Health_x000D_

• Idexx Laboratories Inc._x000D_

• Bio-Rad Laboratories Inc._x000D_

What Are the Most Prominent Trends Driving Change in the Porcine Epidemic Diarrhea Vaccines Market?

Prominent firms in the porcine epidemic diarrhea vaccines market are coming up with ground-breaking products like the Porcine Parvovirus (PPV) vaccine to fortify their standing in the market. The PPV vaccine is a veterinary immunization developed to prevent PPV induced reproductive failure in pigs, a small non-enveloped virus that is associated with issues like infertility, stillbirths, mummified foetuses, and feeble piglets. For example, in March 2022, Boehringer Ingelheim, a pharmaceutical giant based in Germany, introduced the ReproCyc ParvoFLEX, a PPV vaccine. This novel vaccine is formulated to fight against reproductive failure in pigs due to PPV. What sets this launch apart is the advanced formulation and effectiveness of the vaccine that provide broad protection against PPV-induced reproductive issues, ensuring the well-being and productivity of pig herds.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

What Are the Core Segments of the Porcine Epidemic Diarrhea Vaccines Market, and How Do They Contribute to Growth?

The porcine epidemic diarrhea vaccines market covered in this report is segmented –

1) By Product: Live Vaccines, Killed Vaccines

2) By Application: Piglets, Adults Pigs

3) By End-User: Veterinary Hospitals, Hog Production Farms

Subsegments:

1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines

2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines

What Regions Are Leading the Charge in the Porcine Epidemic Diarrhea Vaccines Market?

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Porcine Epidemic Diarrhea Vaccines Market Categorized and Defined in the Industry?

Porcine epidemic diarrhea (PED) vaccines are biological preparations developed to provide immunity against the porcine epidemic diarrhea virus (PEDV), which causes severe gastrointestinal disease in pigs. These vaccines are essential tools in preventing and controlling Porcine Epidemic Diarrhea, contributing to the health and productivity of pig populations and the economic stability of the swine industry.

Browse Through More Similar Reports By The Business Research Company:

Cancer Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Expansion Rate of the Porcine Epidemic Diarrhea Vaccines Market in the 2024-2033 Forecast?

The porcine epidemic diarrhea vaccines market has shown strong growth. It is expected to rise from $1.56 billion in 2023 to $1.67 billion in 2024, at a CAGR of 7.4%. Contributing factors include extensive vaccination campaigns, expanded immunization programs, the use of disposable syringes, efforts to eradicate diarrhea, and initiatives from organizations like GAVI.

The porcine epidemic diarrhea vaccines market is expected to see significant growth, projected to reach $2.25 billion by 2028 at a CAGR of 7.7%. Growth drivers include a focus on immunization programs, expanded vaccine development pipelines, increasing pig populations, and rising awareness of preventive healthcare. Major trends include innovations in vaccine delivery devices, a focus on needle-free solutions, and advancements in personalized medicine.

Claim Your Free Sample of the Global Porcine Epidemic Diarrhea Vaccines Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp

What Factors Are Catalyzing the Growth of the Porcine Epidemic Diarrhea Vaccines Market?

The increase in pig farming is expected to support the growth of the porcine epidemic diarrhea vaccines market. This growth is due to rising global demand for pork and advancements in farming practices. Vaccines are crucial for preventing outbreaks, with around 75 million pigs raised in the US as of December 2023, according to the USDA. Therefore, the increase in pig farming is driving the porcine epidemic diarrhea vaccines market.

Which Segments Are Important in the Porcine Epidemic Diarrhea Vaccines Market Landscape?

1) By Product: Live Vaccines, Killed Vaccines

2) By Application: Piglets, Adults Pigs

3) By End-User: Veterinary Hospitals, Hog Production Farms

What Are the Groundbreaking Trends in the Porcine Epidemic Diarrhea Vaccines Market?

In the porcine epidemic diarrhea vaccines market, companies are introducing innovative products like the porcine parvovirus (PPV) vaccine to strengthen their market position. In March 2022, Boehringer Ingelheim, a German pharmaceutical company, launched the ReproCyc ParvoFLEX vaccine aimed at preventing reproductive failures in pigs.

Order Now for Fast Delivery of Your Porcine Epidemic Diarrhea Vaccines Market Report!

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

What Are the Key Regions Powering Growth in the Porcine Epidemic Diarrhea Vaccines Market?

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2023. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Porcine Epidemic Diarrhea Vaccines Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the porcine epidemic diarrhea vaccines market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Porcine Epidemic Diarrhea Vaccines Market Include

1. Porcine Epidemic Diarrhea Vaccines Market Executive Summary

2. Porcine Epidemic Diarrhea Vaccines Market Segments

3. Porcine Epidemic Diarrhea Vaccines Market Size And Template Market Growth Rate

4. Key Porcine Epidemic Diarrhea Vaccines Market Trends

5. Major Porcine Epidemic Diarrhea Vaccines Market Drivers

……

25. Key Mergers And Acquisitions In The Porcine Epidemic Diarrhea Vaccines Market

26. Top Porcine Epidemic Diarrhea Vaccines Companies

27. Porcine Epidemic Diarrhea Vaccines Market Opportunities And Strategies

28. Porcine Epidemic Diarrhea Vaccines Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Vaccine Adjuvants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Pediatric Vaccine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Expansion Rate of the Porcine Epidemic Diarrhea Vaccines Market in the 2024-2033 Forecast?

The porcine epidemic diarrhea vaccines market has shown strong growth. It is expected to rise from $1.56 billion in 2023 to $1.67 billion in 2024, at a CAGR of 7.4%. Contributing factors include extensive vaccination campaigns, expanded immunization programs, the use of disposable syringes, efforts to eradicate diarrhea, and initiatives from organizations like GAVI.

The porcine epidemic diarrhea vaccines market is expected to see significant growth, projected to reach $2.25 billion by 2028 at a CAGR of 7.7%. Growth drivers include a focus on immunization programs, expanded vaccine development pipelines, increasing pig populations, and rising awareness of preventive healthcare. Major trends include innovations in vaccine delivery devices, a focus on needle-free solutions, and advancements in personalized medicine.

Claim Your Free Sample of the Global Porcine Epidemic Diarrhea Vaccines Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp

What Factors Are Catalyzing the Growth of the Porcine Epidemic Diarrhea Vaccines Market?

The increase in pig farming is expected to support the growth of the porcine epidemic diarrhea vaccines market. This growth is due to rising global demand for pork and advancements in farming practices. Vaccines are crucial for preventing outbreaks, with around 75 million pigs raised in the US as of December 2023, according to the USDA. Therefore, the increase in pig farming is driving the porcine epidemic diarrhea vaccines market.

Which Segments Are Important in the Porcine Epidemic Diarrhea Vaccines Market Landscape?

1) By Product: Live Vaccines, Killed Vaccines

2) By Application: Piglets, Adults Pigs

3) By End-User: Veterinary Hospitals, Hog Production Farms

What Are the Groundbreaking Trends in the Porcine Epidemic Diarrhea Vaccines Market?

In the porcine epidemic diarrhea vaccines market, companies are introducing innovative products like the porcine parvovirus (PPV) vaccine to strengthen their market position. In March 2022, Boehringer Ingelheim, a German pharmaceutical company, launched the ReproCyc ParvoFLEX vaccine aimed at preventing reproductive failures in pigs.

Order Now for Fast Delivery of Your Porcine Epidemic Diarrhea Vaccines Market Report!

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

What Are the Key Regions Powering Growth in the Porcine Epidemic Diarrhea Vaccines Market?

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2023. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Porcine Epidemic Diarrhea Vaccines Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the porcine epidemic diarrhea vaccines market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Porcine Epidemic Diarrhea Vaccines Market Include

1. Porcine Epidemic Diarrhea Vaccines Market Executive Summary

2. Porcine Epidemic Diarrhea Vaccines Market Segments

3. Porcine Epidemic Diarrhea Vaccines Market Size And Template Market Growth Rate

4. Key Porcine Epidemic Diarrhea Vaccines Market Trends

5. Major Porcine Epidemic Diarrhea Vaccines Market Drivers

……

25. Key Mergers And Acquisitions In The Porcine Epidemic Diarrhea Vaccines Market

26. Top Porcine Epidemic Diarrhea Vaccines Companies

27. Porcine Epidemic Diarrhea Vaccines Market Opportunities And Strategies

28. Porcine Epidemic Diarrhea Vaccines Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Vaccine Adjuvants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Pediatric Vaccine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Industry: Pharmaceuticals

Meta Keywords: polyethylene terephthalate (pet) cups market forecast, polyethylene terephthalate (pet) cups market data, polyethylene terephthalate (pet) cups market outlook, polyethylene terephthalate (pet) cups market growth, polyethylene terephthalate (pet) cups market size, polyethylene terephthalate (pet) cups market overview

The Business Research Company offers the porcine epidemic diarrhea vaccines market research report 2024 with industry size, share, segments and market growth

Global Porcine Epidemic Diarrhea Vaccines Market, Global Porcine Epidemic Diarrhea Vaccines Market Report, Global Porcine Epidemic Diarrhea Vaccines Market Trends, Global Porcine Epidemic Diarrhea Vaccines Market Size

The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The porcine epidemic diarrhea (PED) vaccines market has experienced significant growth in recent years and is poised for continued expansion. Below, we explore the driving factors, major trends, and key developments shaping this market.

Recent Market Growth and Projections

Steady Growth in Recent Years

• The PED vaccines market grew from $1.56 billion in 2023 to $1.67 billion in 2024.
• This growth is driven by a compound annual growth rate (CAGR) of 7.4%.
• Key contributors include large-scale vaccination campaigns, expanded immunization programs (EPI), and increased efforts to eradicate diarrhea.

Strong Future Outlook

• The market is projected to reach $2.25 billion by 2028, with a CAGR of 7.7%.
• Growth drivers include an expanding vaccine development pipeline, a growing pig population, and increased awareness of preventive healthcare.
• Advancements in vaccine delivery technology and cold chain management are also expected to play a significant role.

View More On The Porcine Epidemic Diarrhea Vaccines Market Report 2024 – https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Driving Factors Behind Market Expansion

Increasing Pig Farming

• The rise in pig farming is a significant driver of the PED vaccines market.
• Increased global demand for pork products and advancements in farming techniques contribute to this growth.
• For instance, the U.S. raised around 75 million hogs and pigs as of December 2023.
• In the UK, pork on agricultural holdings increased by 9% from December 2020 to December 2021.

Importance of Vaccination in Pig Farming

• PED vaccines are critical in preventing and managing outbreaks in pig farming.
• These vaccines are administered to sows during gestation to provide passive immunity to newborn piglets.
• The growing pig farming industry is directly driving the demand for PED vaccines.

Major Trends in the PED Vaccines Market

Innovations in Vaccine Delivery

• The market is witnessing continuous innovations in vaccine delivery devices.
• A significant trend is the shift towards needle-free solutions, which offer a safer and more efficient vaccination process.

Advancements in Personalized Medicine

• There is a growing preference for personalized medicine in the animal health sector.
• Personalized vaccines tailored to specific needs are expected to become more prevalent.

Strengthening Animal Healthcare Infrastructure

• Efforts to strengthen animal healthcare infrastructure and distribution networks are underway.
• This includes expanding veterinary services and ensuring efficient cold chain management for vaccine storage and distribution.

Key Developments in the Market

Innovative Porcine Parvovirus (PPV) Vaccines

• Leading companies are developing new products, such as the Porcine Parvovirus (PPV) vaccine, to combat reproductive failure in pigs.
• Boehringer Ingelheim launched the ReproCyc ParvoFLEX PPV vaccine in March 2022, offering comprehensive protection against PPV-induced reproductive losses.

Strategic Acquisitions

• In September 2021, Vaxxinova International BV acquired Newport Laboratories from Boehringer Ingelheim.
• This acquisition strengthens Vaxxinova’s portfolio of livestock vaccines, particularly in the swine sector.

Market Segmentation and Regional Insights

Product Segmentation

• The PED vaccines market is segmented by product into live vaccines and killed vaccines.
• Both product types are crucial for different stages of piglet and adult pig care.

Application and End-User

• The vaccines are used for piglets and adult pigs, with end-users including veterinary hospitals and hog production farms.

Regional Insights

• Asia-Pacific was the largest region in the PED vaccines market in 2023, reflecting the region’s significant pork production industry.

The porcine epidemic diarrhea vaccines market is set to continue its robust growth trajectory, driven by innovations in vaccine technology, expanding pig farming practices, and strategic industry developments.

Request A Sample Of The Global Porcine Epidemic Diarrhea Vaccines Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16514&type=smp